Leadership
Cornerstone’s experienced management team has a long and successful track record of discovering and developing novel therapeutics and of leading successful entrepreneurial life sciences ventures. In addition, Cornerstone’s team has operating and leadership experience in all core aspects of building a successful biotechnology company focused on cancer metabolism. These areas of leadership include the basic science of cancer metabolism, drug discovery, drug development, business development and finance. Most importantly, Cornerstone’s management brings a deep passion for discovering and developing more effective therapies for treating cancer.
- Robert Shorr, Ph.D.Chief Executive Officer
- Robert Rodriguez, B.Sc., M.B.A.President & Chief Operating Officer
- Timothy SullivanExecutive Vice President and Head of Corporate Development
- Clifford H. StraubVice President and Chief Financial Officer
- David A. Polinsky, Esq.Vice President and General Counsel
- Paul Bingham, Ph.D.Vice President of Research
- Zuzana Zachar, M.Sc., Ph.D.Director of Research
- King C. Lee, Ph.D.,Vice President, Regulatory and Clinical Affairs
- Patrick P. ZaretskiDirector of Intellectual Property
- Dr. Frank GibsonDirector of Product Development
